Reinvent CRT

General Information Age Group Adults Status Recruiting Protocol Number n/a Background Information The primary objective is to determine if implantation of a permanent CRT pacing device can improve electromechanical function, HF symptoms and natriuretic peptide levels among patients with HF, LVEF > 35% and LBBB. Principal Investigator Brett Atwater, MD Eligibility Information Strict LBBB defined as QRS duration ≥ 130 ms in women and ≥ 140 ms in men, NYHA II / III or ambulatory IV, stable guideline directed HF medical regimen. Ineligibility Information Anticipated addition or titration of HF medical therapies Unrevascularized coronary artery disease, unstable angina Contact Information Contact Name Tracy Plummer Contact Phone 703-776-3567 Contact Email Send Email